5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.36%
Revenue growth at 50-75% of HUH1V.HE's 8.37%. Martin Whitman would worry about competitiveness or product relevance.
-7.00%
Negative gross profit growth while HUH1V.HE is at 6.26%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.32%
Negative EBIT growth while HUH1V.HE is at 32.94%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-22.32%
Negative operating income growth while HUH1V.HE is at 32.94%. Joel Greenblatt would press for urgent turnaround measures.
-22.45%
Negative net income growth while HUH1V.HE stands at 36.39%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-20.00%
Negative EPS growth while HUH1V.HE is at 35.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while HUH1V.HE is at 35.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.06%
Share reduction while HUH1V.HE is at 0.10%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.06%
Reduced diluted shares while HUH1V.HE is at 0.10%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
20.20%
OCF growth under 50% of HUH1V.HE's 517.57%. Michael Burry might suspect questionable revenue recognition or rising costs.
12.87%
FCF growth under 50% of HUH1V.HE's 336.22%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-15.64%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 61.33%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-13.13%
Negative 5Y CAGR while HUH1V.HE stands at 26.04%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.03%
3Y revenue/share CAGR under 50% of HUH1V.HE's 9.67%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
272.69%
10Y OCF/share CAGR above 1.5x HUH1V.HE's 23.26%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
926.17%
5Y OCF/share CAGR above 1.5x HUH1V.HE's 62.01%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-31.90%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 35.64%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
141.86%
Net income/share CAGR 1.25-1.5x HUH1V.HE's 119.33%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
100.00%
5Y net income/share CAGR similar to HUH1V.HE's 99.93%. Walter Schloss might see both on parallel mid-term trajectories.
-20.00%
Negative 3Y CAGR while HUH1V.HE is 65.77%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
22.37%
Below 50% of HUH1V.HE's 52.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
22.73%
3Y equity/share CAGR at 50-75% of HUH1V.HE's 30.76%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
219.32%
5Y dividend/share CAGR above 1.5x HUH1V.HE's 43.64%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
98.48%
3Y dividend/share CAGR above 1.5x HUH1V.HE's 33.68%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.31%
AR growth well above HUH1V.HE's 7.64%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.36%
Inventory is declining while HUH1V.HE stands at 7.80%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.39%
Negative asset growth while HUH1V.HE invests at 7.10%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.92%
BV/share growth above 1.5x HUH1V.HE's 0.81%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-21.68%
We’re deleveraging while HUH1V.HE stands at 15.95%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.22%
SG&A growth well above HUH1V.HE's 10.63%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.